SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-097170
Filing Date
2024-08-14
Accepted
2024-08-14 17:05:46
Documents
101
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K aplm-20240630.htm   iXBRL 6-K 123719
2 EX-99.1 aplm-ex99_1.htm   iXBRL EX-99.1 1256445
3 EX-99.2 aplm-ex99_2.htm EX-99.2 384725
4 EX-99.3 aplm-ex99_3.htm EX-99.3 178114
5 GRAPHIC img229661942_0.jpg GRAPHIC 179240
6 GRAPHIC img230585463_0.jpg GRAPHIC 3563
  Complete submission text file 0000950170-24-097170.txt   9390287

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aplm-20240630.xsd EX-101.SCH 2214307
104 EXTRACTED XBRL INSTANCE DOCUMENT aplm-20240630_htm.xml XML 1360331
Mailing Address 989 EAST HILLSDALE BLVD. STE 220 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BLVD. STE 220 FOSTER CITY CA 94404 1-650-209-4055
Apollomics Inc. (Filer) CIK: 0001944885 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41670 | Film No.: 241209375
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)